Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3774)
All Articles published online
|
Nov 15, 2004 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu C, Wang J, Ou QJ. Possible stem cell origin of human cholangiocarcinoma. World J Gastroenterol 2004; 10(22): 3374-3376 [PMID: 15484322 DOI: 10.3748/wjg.v10.i22.3374] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i22/3374.htm |
| Number | Citing Articles |
| 1 |
Weina Wang, Liyan Shui, Yanning Liu, Min Zheng. C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.598855
|
| 2 |
Yongqin Ye, Vincent Chi Hang Lui, Rosana Ottakandathil Babu, Zhongluan Wu, Weifang Wu, Patrick Ho Yu Chung, Kenneth Kak Yuen Wong, Bin Wang, Paul Kwong Hang Tam, Gianfranco D. Alpini. Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids. PLOS ONE 2023; 18(3): e0283737 doi: 10.1371/journal.pone.0283737
|
| 3 |
Xin-Yuan Lu, Tao Xi, Wan-Yee Lau, Hui Dong, Zhen Zhu, Feng Shen, Meng-Chao Wu, Wen-Ming Cong. Hepatocellular Carcinoma Expressing Cholangiocyte Phenotype Is a Novel Subtype with Highly Aggressive Behavior. Annals of Surgical Oncology 2011; 18(8): 2210 doi: 10.1245/s10434-011-1585-7
|
| 4 |
Jun Ma, Li Weng, Zhongmin Wang, Yiping Jia, Bingyan Liu, Shaoqiu Wu, Yan Cao, Xianjun Sun, Xiang Yin, Mingyi Shang, Aiwu Mao. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2–STAT3 signaling axis. Experimental Cell Research 2018; 366(2): 103 doi: 10.1016/j.yexcr.2018.02.037
|
| 5 |
Susumu Ohfuji. Cholangiocarcinoma of possibly hepatic progenitor cell origin in a cow. Veterinary Quarterly 2012; 32(3-4): 183 doi: 10.1080/01652176.2012.749363
|
| 6 |
Qingfeng Chen, Maroun Khoury, Gino Limmon, Mahesh Choolani, Jerry K.Y. Chan, Jianzhu Chen. Human Fetal Hepatic Progenitor Cells Are Distinct from, but Closely Related to, Hematopoietic Stem/Progenitor Cells. Stem Cells 2013; 31(6): 1160 doi: 10.1002/stem.1359
|
| 7 |
Fernando S Ramalho, Leandra NZ Ramalho, Livia Della Porta, Sérgio Zucoloto. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2006; 21(8): 1276 doi: 10.1111/j.1440-1746.2006.04309.x
|
| 8 |
Yong-Jun Chen, Qi-Bin Tang, Shen-Quan Zou. Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2005; 11(9): 1333-1338 doi: 10.3748/wjg.v11.i9.1333
|
| 9 |
Michail Papoulas, Stamatios Theocharis. Primary liver tumors: origin and target therapy. Expert Opinion on Therapeutic Targets 2009; 13(8): 957 doi: 10.1517/14728220903074588
|
| 10 |
Surya K. De. Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth
Factor Receptors for Treatment of the Bile Duct Cancer. Current Medicinal Chemistry 2024; 31(6): 666 doi: 10.2174/0929867330666230416152913
|